What is GLEAMER?
GLEAMER is at the forefront of applying artificial intelligence to enhance radiology practices. The company's innovative solutions aim to improve diagnostic accuracy and efficiency for medical professionals, thereby contributing to better patient outcomes. Operating within the rapidly evolving HealthTech landscape, GLEAMER leverages advanced AI algorithms to analyze medical images, providing radiologists with powerful tools to support their clinical decisions. This focus on AI in healthcare positions GLEAMER as a key player in the digital transformation of medical imaging.
How much funding has GLEAMER raised?
GLEAMER has raised a total of $38.2M across 2 funding rounds:
Series A
$8.7M
Series B
$29.5M
Series A (2020): $8.7M with participation from Crista Galli Ventures, Majycc eSanté Invest, Elaia, XAnge, and Macsf
Series B (2023): $29.5M led by Bpifrance, Supernova Invest, Heal Capital, and XAnge
Key Investors in GLEAMER
Bpifrance
Bpifrance is a French public investment bank that finances companies across all stages of development, supporting innovation and international expansion. They offer credit, guarantees, and equity, along with consulting and acceleration programs.
Supernova Invest
Supernova Invest is a venture capital firm specializing in deeptech leaders, providing expertise and capital for high-growth startups in sectors like Industrial Technologies, Digital, Healthcare, and Cleantech.
Heal Capital
Heal Capital is a European venture capital firm focused on HealthTech and AI, investing in mission-driven startups from Pre-Seed to Series A stages and providing access to the healthcare system.
What's next for GLEAMER?
The recent major strategic investment in GLEAMER's Series B funding round signals a strong confidence from investors in the company's future potential and its capacity for scaling operations. This capital infusion is expected to fuel further research and development, expand market reach, and potentially drive international growth. As GLEAMER continues to innovate in the AI-driven medical technology space, its strategic financing will be crucial in solidifying its position as a leader in radiology solutions and advancing the adoption of AI in healthcare.
See full GLEAMER company page
